Advertisement

Platelet Activation Dynamics in Kawasaki Disease– Revisited

  • Pandiarajan Vignesh
  • Surjit SinghEmail author
Editorial Commentary

Notes

Compliance with Ethical Standards

Conflict of Interest

None.

Source of Funding

None.

References

  1. 1.
    McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99.CrossRefGoogle Scholar
  2. 2.
    Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. Circ J. 2014;78:188–93.CrossRefGoogle Scholar
  3. 3.
    Jin J, Wang J, Lu Y, et al. Platelet-derived microparticles: a new index of monitoring platelet activation and inflammation in Kawasaki disease. Indian J Pediatr. 2018.  https://doi.org/10.1007/s12098-018-2765-2.
  4. 4.
    Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease. Circ J. 2015;79:1349–56.CrossRefGoogle Scholar
  5. 5.
    Laurito M, Stazi A, Delogu AB, et al. Endothelial and platelet function in children with previous Kawasaki disease. Angiology. 2014;65:716–22.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  1. 1.Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics CentrePostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations